112 related articles for article (PubMed ID: 2458532)
1. Effect of cholecystokinin tetrapeptide amide on the metabolism of 5-hydroxytryptamine in the rat brain.
Itoh S; Takashima A; Katsuura G
Neuropharmacology; 1988 Apr; 27(4):427-31. PubMed ID: 2458532
[TBL] [Abstract][Full Text] [Related]
2. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
Katsuura G; Itoh S
Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
[TBL] [Abstract][Full Text] [Related]
3. The effects of a single dose and prolonged benzene administration on 5-hydroxytryptamine and 5-hydroxyindolacetic acid content in rat brain.
Paradowski M; Heimburger M; Cohen Y; Andrzejewski S
Xenobiotica; 1984 Oct; 14(10):781-4. PubMed ID: 6209865
[TBL] [Abstract][Full Text] [Related]
4. [Effect of C-terminal tetrapeptide cholecystokinin (CCK-4) on the function of the islands of Langerhans and the adenohypophysis].
Fedotov VP; Sadovnikova NV; Gudoshnikov VI; Batrameeva LA; Aleshina LV
Biull Eksp Biol Med; 1984 Jun; 97(6):729-31. PubMed ID: 6146360
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat.
Agnati LF; Fuxe K; Benfenati F; Celani MF; Battistini N; Mutt V; Cavicchioli L; Galli G; Hökfelt T
Neurosci Lett; 1983 Feb; 35(2):179-83. PubMed ID: 6304577
[No Abstract] [Full Text] [Related]
6. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
Katsuura G; Itoh S; Hsiao S
Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors.
Hill RG; Hughes J; Pittaway KM
Neuropharmacology; 1987 Apr; 26(4):289-300. PubMed ID: 3295578
[TBL] [Abstract][Full Text] [Related]
8. Effects of 5-hydroxytryptamine uptake blockers on the concentration in brain of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male rats, pro-oestrous rats and ovariectomized rats treated with oestrogen and progesterone.
Horn AM; Watts AG
J Endocrinol; 1985 Mar; 104(3):407-13. PubMed ID: 2579182
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats.
Hsiao S; Katsuura G; Itoh S
Life Sci; 1984 May; 34(22):2165-8. PubMed ID: 6727557
[TBL] [Abstract][Full Text] [Related]
10. Exogenous tryptophan increases synthesis, storage, and intraneuronal metabolism of 5-hydroxytryptamine in the rat hypothalamus.
Lookingland KJ; Shannon NJ; Chapin DS; Moore KE
J Neurochem; 1986 Jul; 47(1):205-12. PubMed ID: 2423645
[TBL] [Abstract][Full Text] [Related]
11. Time course of changes in serotonin and noradrenaline in rat brain after predictable or unpredictable shock.
Adell A; Trullas R; Gelpi E
Brain Res; 1988 Aug; 459(1):54-9. PubMed ID: 2458804
[TBL] [Abstract][Full Text] [Related]
12. Effect of imipramine on central 5-hydroxytryptamine turnover and metabolism in rats.
Segawa T; Mizuta T
Jpn J Pharmacol; 1980 Dec; 30(6):789-93. PubMed ID: 6165851
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats.
Asin KE; Gore PA; Bednarz L; Holladay M; Nadzan AM
Brain Res; 1992 Jan; 571(1):169-74. PubMed ID: 1611492
[TBL] [Abstract][Full Text] [Related]
14. 5-hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin.
Yang Z; Wrona MZ; Dryhurst G
J Neurochem; 1997 May; 68(5):1929-41. PubMed ID: 9109519
[TBL] [Abstract][Full Text] [Related]
15. MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo.
Whitton PS; Biggs CS; Pearce BR; Fowler LJ
J Neurochem; 1992 Apr; 58(4):1573-5. PubMed ID: 1372346
[TBL] [Abstract][Full Text] [Related]
16. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
Hsiao S; Katsuura G; Itoh S
Behav Neurosci; 1985 Oct; 99(5):853-60. PubMed ID: 3939625
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
Millington WR; Mueller GP; Lavigne GJ
J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of feeding by the C-terminal tetrapeptide fragment of cholecystokinin in a novel environment.
Kádár T; Penke B; Kovács K; Telegdy G
Neuropeptides; 1986; 7(2):97-108. PubMed ID: 3703184
[TBL] [Abstract][Full Text] [Related]
19. The influence of testosterone in the brain of the male rat on levels of serotonin (5-HT) and hydroxyindole-acetic acid (5-HIAA).
Martinez-Conde E; Leret ML; Diaz S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(2):411-4. PubMed ID: 2408817
[TBL] [Abstract][Full Text] [Related]
20. Effects of cholecystokinin tetrapeptide (CCK(4)) and anxiolytic drugs on the electrically evoked [(3)H]5-hydroxytryptamine outflow from rat cortical slices.
Siniscalchi A; Rodi D; Cavallini S; Marino S; Beani L; Bianchi C
Brain Res; 2001 Dec; 922(1):104-11. PubMed ID: 11730707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
